Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3028 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 3.99 USD | -4.55% | -7.64% | -0.25% | +2.31% | 414.49 M USD | ||
| 3032 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.34 USD | -2.50% | +1.74% | +10.90% | -22.26% | 421.41 M USD | ||
| 3050 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 6.73 USD | -4.81% | +3.54% | +36.79% | +64.95% | 399.66 M USD | ||
| 3075 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.01 USD | -0.74% | -4.07% | +3.89% | +35.02% | 397.58 M USD | ||
| 3077 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.77 USD | -2.25% | -2.25% | +1.49% | -2.45% | 391.36 M USD | ||
| 3082 |  CTNM Contineum Therapeutics, Inc. - Common stock | 16.30 USD | -5.18% | +14.47% | +9.99% | +6.75% | 376.52 M USD | ||
| 3083 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.96 USD | -2.92% | -7.98% | +8.51% | +26.71% | 384.34 M USD | ||
| 3097 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.14 USD | -2.45% | -1.35% | +1.39% | +49.15% | 382.71 M USD | ||
| 3114 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.40 USD | -3.13% | -0.29% | +4.29% | -6.59% | 373.23 M USD | ||
| 3119 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 12.92 USD | -3.94% | +61.10% | +128.67% | -30.12% | 367.23 M USD | ||
| 3126 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.51 USD | -6.57% | +5.60% | +13.63% | -40.02% | 355.57 M USD | ||
| 3134 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.08 USD | +0.48% | +8.33% | -2.80% | +278.18% | 376.64 M USD | ||
| 3143 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.64 USD | -1.09% | +6.43% | +4.00% | -10.12% | 367.09 M USD | ||
| 3157 |  PALI Palisade Bio, Inc. - Common Stock | 2.01 USD | -4.29% | -6.51% | +2.55% | +18.24% | 350.28 M USD | ||
| 3159 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 6.63 USD | +5.41% | -7.40% | +13.72% | -6.62% | 385.46 M USD | ||
| 3163 |  AGEN Agenus Inc. - Common Stock | 7.72 USD | -4.57% | +8.89% | +28.88% | +71.56% | 347.56 M USD | ||
| 3193 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.34 USD | -2.76% | -5.23% | -6.63% | +5.32% | 341.89 M USD | ||
| 3204 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.13 USD | -4.33% | -2.19% | -12.40% | +15.76% | 333.78 M USD | ||
| 3205 |  ABEO Abeona Therapeutics Inc. - Common Stock | 6.03 USD | -0.99% | +3.79% | -0.50% | -16.71% | 344.82 M USD | ||
| 3216 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.72 USD | -1.59% | -0.53% | +5.38% | +76.30% | 338.47 M USD |
Notícias Biotechnology Stocks
Dinamarca - Ações fecharam o pregão em alta e o Índice OMX Copenhagen 20 avançou 0,41%
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |